Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4900]

Artificial intelligence approach may help identify melanoma survivors who face a high risk of cancer recurrence

Artificial intelligence approach may help identify melanoma survivors who face a high risk of cancer recurrence

Possible biological explanation for increased cancer risk in dense breasts

Possible biological explanation for increased cancer risk in dense breasts

Cancer treatments may include dietary strategies such as intermittent fasting

Cancer treatments may include dietary strategies such as intermittent fasting

How tumours suppress the development of metastases

How tumours suppress the development of metastases

Preliminary data suggest that ROS1 inhibitor, NVL-520, is well-tolerated and active in non-small cell lung cancer: first results from ARROS-1 phase I clinical trial

Preliminary data suggest that ROS1 inhibitor, NVL-520, is well-tolerated and active in non-small cell lung cancer:...

Anti-cancer drugs, olaparib and adavosertib, work best when given sequentially in patients with advanced tumours driven by DNA damage response mutations: results from phase Ib STAR clinical trial

Anti-cancer drugs, olaparib and adavosertib, work best when given sequentially in patients with advanced tumours...

Experimental drug to treat liver cancer shows evidence of activity with manageable side effects

Experimental drug to treat liver cancer shows evidence of activity with manageable side effects

Studies unveil ‘dark matter’ shaping cancer behaviour

Studies unveil ‘dark matter’ shaping cancer behaviour

Some breast cancer patients with high responses to chemotherapy may not need surgery

Some breast cancer patients with high responses to chemotherapy may not need surgery

Targeted lung cancer drug shows promise in phase I/II clinical trial

Targeted lung cancer drug shows promise in phase I/II clinical trial

More from ecancer